跳至主要内容
临床试验/NCT01887405
NCT01887405已完成4 期

Comparative Evaluation of Handling Characteristics of Two Adrenaline Autoinjectors,EpiPen in Comparison With Jext; the HEJ-study

ALK Nordic A/S, Danmark Filial1 个研究点 分布在 1 个国家目标入组 91 人开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
91
试验地点
1
主要终点
Non-inferiority of Jext compared with EpiPen for the proportion of subjects with a successful self-injection.

研究概览

简要总结

The purpose of the study is to demonstrate non-inferiority of Jext compared with EpiPen for the proportion of subjects with a successful self-injection. And to evaluate and compare the handling characteristics of two auto-injectors (Jext and EpiPen).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent obtained before entering the study 1
  • Prescription of EpiPen or AnaPen for at least 2 months
  • Age ≥16 years
  • Body weight >50 kg
  • Subject willing and able to comply with study protocol

排除标准

  • Any of the following concomitant diseases: cardiovascular disease, e.g. arrhythmias or signs of coronary atherosclerosis, heart failure, uncontrolled hypertension, uncontrolled diabetes mellitus, cancer, hyperthyroidism, severe renal impairment
  • Known blood-born infection, e.g. hepatitis and/or HIV
  • Concomitant treatment with medication which may potentiate the effect of adrenaline, e.g. catechol-O-methyl transferase (COMT) inhibitors, monoamine oxidase (MAO) inhibitors and tricyclic antidepressants
  • Pregnancy
  • Being immediate family of the investigator or study staff, defined as the investigator's/staff's spouse, parent, child, grandparent or grandchild

研究组 & 干预措施

Adrenaline: Session 1 Jext, 2 Epipen

Active Comparator

Subjects will be randomised 1:1 to use Jext in session 1 and EpiPen in session 2.

干预措施: Adrenaline auto-injector (Drug)

Adrenaline: Session 1 Epipen, 2 Jext

Active Comparator

Subjects will be randomised 1:1 to use EpiPen in session 1 and Jext in session 2.

干预措施: Adrenaline auto-injector (Drug)

结局指标

主要结局

Non-inferiority of Jext compared with EpiPen for the proportion of subjects with a successful self-injection.

时间窗: 1 day

The following steps were recorded as correctly done or not by the observer in a check list approach (yes/no): 1. The subject identified the safety cap. 2. The subject removed the safety cap. 3. The subject identified the end of the auto-injector where the needle presents itself 4. The subject used sufficient force to actuate the injection. 5. The subject injected the auto-injector into the anterolateral thigh at a right angle (approximately 90°) to the thigh. 6. The time spent for the injection of adrenaline was more than 10 seconds, i.e. with the needle in situ. If all 6 steps were performed correctly, the injection was considered as successful. These data form the basis for evaluation of the binary primary endpoint (successful injection or not).

次要结局

  • To evaluate and compare the handling characteristics of two auto-injectors (Jext and EpiPen) regarding subject preference for one of the two auto-injectors over the other, the time to perform the injection and any hesitance to perform the injection(1 day)

研究者

发起方
ALK Nordic A/S, Danmark Filial
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验